Sale

Cytokine Market

Global Cytokine Market Analysis, Share, Trends, Forecast: By Cytokine Type: Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF, Other Cytokine Types; By Application: Cancer, Asthma and Airway Inflammation, Arthritis, Other Therapeutic Applications; Regional Analysis; Supplier Landscape; 2024-2032

Global Cytokine Market Outlook

The global cytokine market size was valued at USD 92.67 million in 2023, driven by the rising prevalence for personalised medicine across the globe. The market is expected to grow at a CAGR of 9.8% during the forecast period of 2024-2032, with the values likely to rise from USD 101.75 million in 2024 to USD 214.96 million by 2032.

 

Global Cytokine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Cytokine Market Overview

Cytokine refers to a group of small, short-lived proteins that are released by one cell to regulate the function of another cell, thereby serving as intercellular chemical messengers. Cytokine effect changes in cellular behavior that are important in several physiological processes, including reproduction, growth and development, and injury repair. Cytokines find their application across various therapeutic areas, particularly immunotherapy. Consequently, they are widely used in cancer and autoimmune disorder treatments. As per the data released by American Cancer Society, 2,001,140 new cancer cases and 611,720 cancer deaths are predicted to affect the United States population in 2024. Hence, the cytokine market demand is expected to witness an upswing in the coming years.

 

The market is driven by increasing application of cytokines in drug development and therapeutics along with rising investments from prominent companies to launch novel products and engage in research and development activities to strengthen their market position.

 

Increased Application in Cancer Therapeutics

Advancements in bioengineering have significantly helped in a better understanding of cytokine biology. The knowledge spans from receptor binding and cytokine structures, as a result, cytokine-based immunotherapy is becoming increasingly prevalent in recent years. In April 2023, Synthekine Inc., a United States based, engineered cytokine therapeutics company introduced a clinical trial design for orthogonal IL-2 and CD19 CAR-T combination therapy, STK-009 + SYNCAR-001. The increasing application of cytokines in cancer therapeutics is poised to enhance the cytokine market share in the forecast period.

 

Emphasis on Developing Effective Solutions to Address Multiple Indications

In December 2023, Equillium, Inc., announced an update on their multi-cytokine programs EQ101, and EQ102 to treat alopecia areata, celiac disease respectively. EQ101 was well tolerated in the 24-week dosing period in the Phase 2 study for alopecia areata. EQ102, a bi-specific inhibitor of IL-15 and IL-21, two cytokines central to T and B cell activity, is a potential candidate to treat skin and gastrointestinal diseases. Another promising candidate EQ302 (an orally delivered multi-cytokine inhibitor of IL-15 & IL-21) is also under investigation as it offers significant commercial and clinical benefits over EQ102. The increasing research and development activities in cytokines to address several diseases with efficiency and accuracy is poised to boost the cytokine market size during the forecast period.

 

Advent of New Technologies to Improve the Efficacy of Available Options

The healthcare and biotechnology industry has witnessed various technological advancements in recent years. Technical innovations have led to the emergence of various novel platforms to boost the effectiveness of options available and are anticipated to drive cytokine market growth in the upcoming years. In November 2023, Reverb Therapeutics launched a new Amplifier, an antibody-based platform for treating a broad range of diseases with endogenous cytokines that occur naturally within the body. Financed by Amplitude Ventures and Myeloma Investment Fund, the platform is designed to redirect a cytokine to a specific tumor, immune cell, or tissue, using elements of new and existing antibodies.

 

 

Global Cytokine Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Cytokine Market Segmentation

Market Breakup by Cytokine Type

  • Tumor Necrosis Factor-TNF
  • Interleukins-II
  • Interferons-IFN
  • Epidermal Growth Factor-EGF
  • Other Cytokine Types

 

Market Breakup by Application

  • Cancer
  • Asthma and Airway Inflammation
  • Arthritis
  • Other Therapeutic Applications

 

Market Breakup by Region

  • North America
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

 

Global Cytokine Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Cytokine Market Regional Analysis

North America is expected to lead the market share for cytokines in the forecast period, which can be attributed to a robust research and development infrastructure in the region. The region is witnessing increased collaborations between key healthcare companies and academic institutions to develop effective and innovative solutions for chronic conditions including cancer, among others. Leveraging latest technologies, there is major focus on engineering T cells to carry cytokines IL-15 and IL-21 on their surface, which enhances their ability to kill cancer cells.

 

The Asia Pacific region is poised to witness substantial cytokine market growth in the forecast period. In January 2024, researchers from Osaka University discovered a new way to suppress the cytokine release storm (a condition where the body releases too many cytokines leading to inflammation) by blocking the IL-6 signals and minimizing the side effects. The ongoing research indicates that cytokines are a key area of research amongst scientists. In addition, the increasing technological advancements and infrastructure improvement is predicted to boost market growth in the region.

 

Global Cytokine Market: Competitor Landscape

In May 2023, CytoAgents, Inc., a clinical stage biotech company received FDA’s go ahead to initiate Phase 1b/2a clinical trial for its Investigational New Drug (IND) CTO1681, o treat (cytokine release syndrome) CRS in lymphoma patients receiving CAR T-Cell Therapy. The new drug candidate targets the condition by regulating the body’s natural response to sickness. With the new candidate, the company anticipates accelerating their clinical development efforts.

 

The key features of the cytokine market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • GSK PLC
  • Novartis AG
  • Amgen
  • Pfizer Inc.
  • Sanofi SA
  • AstraZeneca plc
  • Biocon Limited
  • Abbvie Inc
  • Johnson and Johnson
  • UCB S.A.
  • Thermo Fisher Scientific Inc.
  • Novo Nordisk A/S
  • Teva Pharmaceutical Industries Ltd.
  • Sichuan Guoguang agrochemical co. ltd
  • TCI Chemicals (India) Pvt. Ltd.

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Cytokine Type
  • Application
  • Region
Breakup by Cytokine Type
  • Tumor Necrosis Factor-TNF 
  • Interleukins-II 
  • Interferons-IFN 
  • Epidermal Growth Factor-EGF 
  • Other Cytokine Types
Breakup by Application
  • Cancer 
  • Asthma and Airway Inflammation 
  • Arthritis 
  • Other Therapeutic Applications 
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • GSK PLC
  • Novartis AG
  • Amgen
  • Pfizer Inc.
  • Sanofi SA
  • AstraZeneca plc
  • Biocon Limited
  • Abbvie Inc
  • Johnson and Johnson
  • UCB S.A.
  • Thermo Fisher Scientific Inc.
  • Novo Nordisk A/S
  • Teva Pharmaceutical Industries Ltd.
  • Sichuan Guoguang agrochemical co. ltd
  • TCI Chemicals (India) Pvt. Ltd.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Cytokine Market Overview
 
    3.1    Global Cytokine Market Historical Value (2017-2023) 
    3.2    Global Cytokine Market Forecast Value (2024-2032)
4    Global Cytokine Market Landscape
    4.1    Global Cytokine Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Cytokine Product Landscape
        4.2.1    Analysis by Cytokine Type
        4.2.2    Analysis by Application
5    Global Cytokine Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Cytokine Market Segmentation 
    6.1    Global Cytokine Market by Cytokine Type
        6.1.1    Market Overview 
        6.1.2    Tumor Necrosis Factor-TNF 
        6.1.3    Interleukins-II 
        6.1.4    Interferons-IFN 
        6.1.5    Epidermal Growth Factor-EGF 
        6.1.6    Other Cytokine Types 
    6.2    Global Cytokine Market by Application
        6.2.1    Market Overview
        6.2.2    Cancer 
        6.2.3    Asthma and Airway Inflammation 
        6.2.4    Arthritis 
        6.2.5    Other Therapeutic Applications 
    6.3    Global Cytokine Market by Region
        6.3.1    Market Overview
        6.3.2    North America 
        6.3.3    Europe
        6.3.4    Asia Pacific
        6.3.5    Latin America
        6.3.6    Middle East and Africa
7    North America Cytokine Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Cytokine Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Cytokine Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Others
10    Latin America Cytokine Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Cytokine Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by Year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Clinical Trials Analysis
    14.1     Analysis by Trial Registration Year
    14.2    Analysis by Trial Status
    14.3    Analysis by Trial Phase
    14.4    Analysis by Therapeutic Area
    14.5    Analysis by Geography
15    Funding & Investment Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Supplier Landscape
    18.1    GSK PLC 
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications
    18.2    Novartis AG
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    Amgen
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    Pfizer Inc.
        18.4.1    Financial Analysis
        18.4.2    Financial Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Sanofi SA
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    AstraZeneca plc
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    Biocon Limited
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    Abbvie Inc
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
    18.9    Johnson and Johnson
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    UCB S.A.
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
    18.11    Thermo Fisher Scientific Inc.
        18.11.1    Financial Analysis
        18.11.2    Product Portfolio
        18.11.3    Demographic Reach and Achievements
        18.11.4    Mergers and Acquisitions
        18.11.5    Certifications
    18.12    Novo Nordisk A/S
        18.12.1    Financial Analysis
        18.12.2    Product Portfolio
        18.12.3    Demographic Reach and Achievements
        18.12.4    Mergers and Acquisitions
        18.12.5    Certifications
    18.13    Teva Pharmaceutical Industries Ltd.
        18.13.1    Financial Analysis
        18.13.2    Product Portfolio
        18.13.3    Demographic Reach and Achievements
        18.13.4    Mergers and Acquisitions
        18.13.5    Certifications
    18.14    Sichuan Guoguang agrochemical co. ltd
        18.14.1    Financial Analysis
        18.14.2    Product Portfolio
        18.14.3    Demographic Reach and Achievements
        18.14.4    Mergers and Acquisitions
        18.14.5    Certifications
    18.15    TCI Chemicals (India) Pvt. Ltd.
        18.15.1    Financial Analysis
        18.15.2    Product Portfolio
        18.15.3    Demographic Reach and Achievements
        18.15.4    Mergers and Acquisitions
        18.15.5    Certifications
19    Global Cytokine Market - Distribution Model (Additional Insight)
    19.1    Overview 
    19.2    Potential Distributors 
    19.3    Key Parameters for Distribution Partner Assessment 
20    Key Opinion Leaders (KOL) Insights (Additional Insight)
21    Company Competitiveness Analysis (Additional Insight)

    21.1    Very Small Companies
    21.2    Small Companies
    21.3    Mid-Sized Companies
    21.4    Large Companies
    21.5    Very Large Companies
22    Payment Methods (Additional Insight)
    22.1    Government Funded
    22.2    Private Insurance
    22.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 92.67 million in 2023, driven by increasing prevalence of personalised medicine across the globe.

The market is anticipated to grow at a CAGR of 9.8% during the forecast period of 2024-2032, likely to reach a market value of USD 214.96 million by 2032.

The market demand is driven by the rising incidence of chronic diseases in the older population, along with rising technical advancements and increased research and development investments.

The application of cytokines to treat multiple diseases is a major market trend. In December 2023, Equillium, Inc., announced the launch of their multi-cytokine programs EQ101, aimed at treating alopecia areata and EQ102 to treat celiac disease. Another promising candidate EQ302 (an orally delivered multi-cytokine inhibitor of IL-15 & IL-21) is also under investigation.

Based on product types, the market is divided into tumor necrosis factor-TNF, interleukins-II, interferons-IFN, and epidermal growth factor-EGF, among others.

Common application areas include cancer, asthma and airway inflammation, and arthritis, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Key players involved in the market are GSK PLC, Novartis AG, Amgen, Pfizer Inc., Sanofi SA, AstraZeneca plc., Abbvie Inc., Johnson and Johnson, UCB S.A., Thermo Fisher Scientific Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sichuan Guoguang agrochemical co. ltd., TCI Chemicals (India) Pvt. Ltd., and Biocon Limited.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER